The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Ipsen; Lilly; Merck; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche; Sanofi; SERVIER; Takeda
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; EMD Serono; Lilly; Spectrum Pharmaceuticals
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; MSD; Pfizer; Roche
Research Funding - Boehringer Ingelheim; Lilly
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
 
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck KGaA; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck KGaA; Pfizer; Roche
Clinical response to tepotinib according to circulating tumor (ct) DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx).
 
Xiuning Le
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; EMD Serono; Lilly; Spectrum Pharmaceuticals
Research Funding - Boehringer Ingelheim (Inst); Lilly (Inst)
 
Luis Paz-Ares
No Relationships to Disclose
 
Jan Van Meerbeeck
Consulting or Advisory Role - Amgen
 
Santiago Viteri Ramirez
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Merck KGaA; Puma Biotechnology; Reddy Pharma Iberia; Roche; Takeda
Speakers' Bureau - AstraZeneca Spain; Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Merck KGaA; Merck KGaA; MSD; Roche
 
Carlos Cabrera Galvez
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - MSD; Roche
 
David Vicente Baz
No Relationships to Disclose
 
Young-Chul Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; MSD; Ono Pharmaceutical; Pfizer; Roche; Yuhan
Research Funding - AstraZeneca; Boehringer Ingelheim; Roche
 
Jin-Hyoung Kang
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; MSD; Novartis; Roche; Takeda; Yuhan
Speakers' Bureau - MSD; Pfizer; Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Yuhan
 
Christopher Stroh
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
Patents, Royalties, Other Intellectual Property - Predictive biomarker for anti-EGFR therapy
 
Dilafruz Juraeva
Employment - Merck
Stock and Other Ownership Interests - Merck KGaA
 
Rolf Bruns
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
Gordon Otto
Employment - Merck KGaA
Stock and Other Ownership Interests - Novartis
 
Andreas Johne
Employment - Merck KGaA
 
Paul K. Paik
Honoraria - Bicara Therapeutics; EMD Serono; Mirati Therapeutics; Takeda; Xencor
Consulting or Advisory Role - Bicara Therapeutics; Calithera Biosciences; EMD Serono; Mirati Therapeutics; Takeda; Xencor
Research Funding - Bicara Therapeutics; Boehringer Ingelheim; EMD Serono